Read more

October 18, 2019
2 min watch
Save

VIDEO: Omidria helps improve cataract surgery experience

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN FRANCISCO — Eric Donnenfeld, MD, discusses a recent study of Omidria (phenylephrine 1% and ketorolac 0.3% intraocular solution, Omeros) at the American Academy of Ophthalmology meeting. Results found 90% of patients treated with Omidria were less likely to need opioids during surgery.